Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy Wang

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Geohealth|June 19, 2026
Hybrid Supervised-Unsupervised Modeling for Post-Hurricane Private Well Contamination Risk Score Using Empirical Validation and Community-Informed AssessmentJilei Lin, Jennifer Zhang, Ellen Wei, et al.
Nature Communications|June 16, 2019
Altered NMDAR signaling underlies autistic-like features in mouse models of CDKL5 deficiency disorderSheng Tang, Barbara Terzic, I-Ting Judy Wang, et al.
The Oncologist|March 24, 2022
Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C MutationJudy Wang, Patricia Martin-Romano, Philippe Cassier, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in miceI-Ting Judy Wang, Megan Allen, Darren Goffin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working GroupThomas S Uldrick, Gwynn Ison, Michelle A Rudek, et al.
Annals of Surgical Oncology|November 28, 2023
Association of Race, Ethnicity, Language, and Insurance with Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net HospitalBrendin R Beaulieu-Jones, Emily J Ha, Ann Fefferman, et al.
World Neurosurgery|December 22, 2018
Endovascular Retrieval of Dislodged Neurovascular Devices with a Stentriever: Case Series and Technical ReviewKevin Z Zhou, Julian Maingard, Hong Kuan Kok, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 10, 2015
AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodyniaSonya G Lehto, Andy D Weyer, Maosheng Zhang, et al.
British Journal of Clinical Pharmacology|April 27, 2025
A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect levelLin Yuan, Meghana Kulkarni, Evan Chiswick, et al.
Journal of the American Heart Association|July 15, 2018
Gastrin Protects Against Myocardial Ischemia/Reperfusion Injury via Activation of RISK (Reperfusion Injury Salvage Kinase) and SAFE (Survivor Activating Factor Enhancement) PathwaysXiaoli Yang, Rongchuan Yue, Jun Zhang, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Geohealth|June 19, 2026
Hybrid Supervised-Unsupervised Modeling for Post-Hurricane Private Well Contamination Risk Score Using Empirical Validation and Community-Informed AssessmentJilei Lin, Jennifer Zhang, Ellen Wei, et al.
Nature Communications|June 16, 2019
Altered NMDAR signaling underlies autistic-like features in mouse models of CDKL5 deficiency disorderSheng Tang, Barbara Terzic, I-Ting Judy Wang, et al.
The Oncologist|March 24, 2022
Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C MutationJudy Wang, Patricia Martin-Romano, Philippe Cassier, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in miceI-Ting Judy Wang, Megan Allen, Darren Goffin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working GroupThomas S Uldrick, Gwynn Ison, Michelle A Rudek, et al.
Annals of Surgical Oncology|November 28, 2023
Association of Race, Ethnicity, Language, and Insurance with Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net HospitalBrendin R Beaulieu-Jones, Emily J Ha, Ann Fefferman, et al.
World Neurosurgery|December 22, 2018
Endovascular Retrieval of Dislodged Neurovascular Devices with a Stentriever: Case Series and Technical ReviewKevin Z Zhou, Julian Maingard, Hong Kuan Kok, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 10, 2015
AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodyniaSonya G Lehto, Andy D Weyer, Maosheng Zhang, et al.
British Journal of Clinical Pharmacology|April 27, 2025
A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect levelLin Yuan, Meghana Kulkarni, Evan Chiswick, et al.
Journal of the American Heart Association|July 15, 2018
Gastrin Protects Against Myocardial Ischemia/Reperfusion Injury via Activation of RISK (Reperfusion Injury Salvage Kinase) and SAFE (Survivor Activating Factor Enhancement) PathwaysXiaoli Yang, Rongchuan Yue, Jun Zhang, et al.
Pageof 9